Regarding the antidiabetic effect, FFA1 has been widely investigated as a molecular target for diabetes, mainly due to the glucose-stimulated insulin secretion via protein kinase C/inositol triphosphate (PKC/IP3) activation and, consequently, intracellular calcium increase, inducing insulin release [57,58]. Here, INS is linked to diabetes mellitus.